ScaleUp Partners
Overview
ScaleUp Partners is a South Korean venture capital and accelerator firm that invests in and supports early-stage deep tech, bio-healthcare, and IT startups.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| UBIX BIO INC. | Mar 2023 | Series C | Co-investor |
| ARKgen BioScions | Jul 2026 | Series A | Co-investor |
| BioMe Inc. | Dec 2024 | Series A | Co-investor |
| MicrobiotiX Co.,LTD | Mar 2022 | VC Round | Co-investor |
| Huniverse Global | May 2022 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Peter Schier
Engineering Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is ScaleUp Partners based?
ScaleUp Partners is headquartered in Seoul, South Korea.
When was ScaleUp Partners founded?
ScaleUp Partners was founded in 2020.
How many portfolio companies does ScaleUp Partners have?
ScaleUp Partners has 6 portfolio companies in Caplight's dataset.
What are some companies in ScaleUp Partners's portfolio?
Portfolio companies visible on Caplight include UBIX BIO INC., ARKgen BioScions, BioMe Inc., MicrobiotiX Co.,LTD, Huniverse Global.
What was ScaleUp Partners's most recent investment shown here?
ScaleUp Partners's most recent investment in this portfolio sample was in ARKgen BioScions in 2026.
What sectors does ScaleUp Partners focus on?
ScaleUp Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does ScaleUp Partners focus on?
ScaleUp Partners typically invests at the Mid stage.
What is ScaleUp Partners's AUM?
ScaleUp Partners's assets under management are estimated between $66.3M and $66.3M.